Vivos Therapeutics, Inc. Share Price

Equities

VVOS

US92859E2072

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 02:00:01 14/05/2024 am IST 5-day change 1st Jan Change
2.01 USD -5.41% Intraday chart for Vivos Therapeutics, Inc. -15.55% -83.84%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 16.1M 1.34B Sales 2025 * 19.11M 1.6B Capitalization 5.99M 500M
Net income 2024 * -10M -835M Net income 2025 * -10M -835M EV / Sales 2024 * 0.37 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.31 x
P/E ratio 2024 *
-0.51 x
P/E ratio 2025 *
-0.88 x
Employees 119
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.41%
1 week-15.55%
Current month-20.55%
1 month-23.86%
3 months-60.97%
6 months-40.88%
Current year-83.84%
More quotes
1 week
1.96
Extreme 1.9601
2.48
1 month
1.96
Extreme 1.9601
2.90
Current year
1.96
Extreme 1.9601
12.75
1 year
1.96
Extreme 1.9601
48.79
3 years
1.96
Extreme 1.9601
177.25
5 years
1.96
Extreme 1.9601
360.25
10 years
1.96
Extreme 1.9601
360.25
More quotes
Managers TitleAgeSince
Founder - 07/16/07
Founder - 07/16/07
Founder - 07/16/07
Members of the board TitleAgeSince
Director/Board Member 67 01/20/01
Director/Board Member 61 01/20/01
Director/Board Member 56 01/20/01
More insiders
Date Price Change Volume
13/24/13 2.01 -5.41% 131,348
10/24/10 2.125 -2.97% 120,500
09/24/09 2.19 -7.79% 128,160
08/24/08 2.375 -2.26% 38,384
07/24/07 2.43 +2.10% 50,024

Delayed Quote Nasdaq, May 14, 2024 at 02:00 am IST

More quotes
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.01 USD
Average target price
7.225 USD
Spread / Average Target
+259.45%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW